Healthcare, Regulatory and Reimbursement Landscape - the Netherlands New Report
Healthcare, Regulatory and Reimbursement Landscape - The Netherlands. The report is an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in the Netherlands. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. In 2011, the population of the Netherlands was 16.7 million. The population...
View full press release